Globus Medical
Stock Forecast, Prediction & Price Target
Globus Medical (GMED) stock Price Target by analysts
$100
Potential upside: 73.63%
Globus Medical price prediction
What is Globus Medical stock analysts` prediction?
Globus Medical stock forecast: Based on 1 Wall Street analysts` predicted price targets for Globus Medical in the last 3 months, the avarage price target is $100, with a high forecast of $NaN. The average price target represents a 73.63% change from the last price of $57.59.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Globus Medical stock Price Target by analysts
Full breakdown of analysts given Globus Medical price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Kallum Titchmarsh Morgan Stanley | 0% 0/1 | 9 months ago | $100 73.63% upside | $85.52 | StreetInsider | Previous targets (0) |
Ryan Zimmerman BTIG | 0% 0/3 | about 1 year ago | $77 33.69% upside | $71.73 | TheFly | Previous targets (2) |
Vik Chopra Wells Fargo | 0% 0/1 | about 1 year ago | $78 35.43% upside | $70.53 | StreetInsider | Previous targets (0) |
Drew Ranieri Morgan Stanley | 0% 0/1 | about 1 year ago | $71 23.27% upside | $71.07 | TheFly | Previous targets (0) |
Ryan Zimmerman BTIG | 0% 0/3 | over 1 year ago | $72 25.01% upside | $65.49 | StreetInsider | Previous targets (2) |
Matt O'Brien Piper Sandler | 0% 0/1 | over 1 year ago | $80 38.90% upside | $64.4 | TheFly | Previous targets (0) |
Ryan Zimmerman BTIG | 0% 0/3 | over 1 year ago | $60 4.18% upside | $51.65 | StreetInsider | Previous targets (2) |
Mathew Blackman Stifel Nicolaus | 0% 0/1 | almost 2 years ago | $61 5.91% upside | $53.04 | Benzinga | Previous targets (0) |
Unknown Morgan Stanley | N/A | over 2 years ago | $78 35.43% upside | $71.98 | Benzinga | N/A |
Unknown Truist Financial | N/A | over 2 years ago | $85 47.58% upside | $71.36 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 2 years ago | $82 42.37% upside | $73.13 | Benzinga | N/A |
Unknown Piper Sandler | N/A | about 3 years ago | $75 30.22% upside | $58.85 | Benzinga | N/A |
Unknown Truist Financial | N/A | about 3 years ago | $71 23.27% upside | $58.36 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $62 7.65% upside | $56.27 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 3 years ago | $68 18.07% upside | $61.17 | Benzinga | N/A |
Unknown Needham | N/A | over 3 years ago | $71 23.27% upside | $61.22 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $73 26.75% upside | $59.97 | Benzinga | N/A |
Craig Bijou Bank of America Securities | 100% 1/1 | over 3 years ago | $80 38.90% upside | $68.96 | Benzinga | Previous targets (0) |
Kyle Rose Canaccord Genuity | 0% 0/1 | about 4 years ago | $90 56.27% upside | $79.9 | StreetInsider | Previous targets (0) |
Richard Newitter Leerink Partners | 0% 0/1 | about 4 years ago | $96 66.68% upside | $79.9 | TipRanks | Previous targets (0) |
Matthew Henriksson Citigroup | 0% 0/1 | about 4 years ago | $93 61.47% upside | $79.9 | StreetInsider | Previous targets (0) |
Steven Lichtman Oppenheimer | 100% 1/1 | over 4 years ago | $79 37.17% upside | $73.37 | TipRanks | Previous targets (0) |
Globus Medical Financial Estimates
Globus Medical Revenue Estimates
Globus Medical EBITDA Estimates
Globus Medical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $958.10M N/A | $1.02B 6.75% | $1.56B 53.34% | Avg: $2.65B Low: $2.64B High: $2.67B avg. 69.06% | Avg: $2.84B Low: $2.82B High: $2.87B avg. 7.39% | Avg: $3.08B Low: $3.06B High: $3.11B avg. 8.48% | Avg: $3.45B Low: $3.42B High: $3.48B avg. 11.89% |
Net Income
% change YoY
| $149.19M N/A | $190.16M 27.46% | $122.87M -35.38% | Avg: $380.91M Low: $246.45M High: $363.37M avg. 210.00% | Avg: $452.58M Low: $280.84M High: $431.00M avg. 18.81% | Avg: $521.85M Low: $516.32M High: $527.29M avg. 15.30% | Avg: $591.49M Low: $585.22M High: $597.65M avg. 13.34% |
EBITDA
% change YoY
| $289.05M N/A | $313.82M 8.56% | $310.12M -1.17% | Avg: $736.38M Low: $733.60M High: $741.94M avg. 137.44% | Avg: $790.81M Low: $784.36M High: $797.15M avg. 7.39% | Avg: $857.93M Low: $850.94M High: $864.81M avg. 8.48% | Avg: $960.01M Low: $952.18M High: $967.70M avg. 11.89% |
EPS
% change YoY
| $1.48 N/A | $1.89 27.70% | $1.09 -42.32% | Avg: $2.78 Low: $2.15 High: $3.17 avg. 155.35% | Avg: $3.3 Low: $2.45 High: $3.76 avg. 18.63% | Avg: $4.55 Low: $4.5 High: $4.6 avg. 37.87% | Avg: $5.16 Low: $5.11 High: $5.21 avg. 13.34% |
Operating Expenses
% change YoY
| $524.02M N/A | $522.86M -0.22% | $887.16M 69.67% | Avg: $1.14B Low: $1.14B High: $1.15B avg. 29.12% | Avg: $1.23B Low: $1.22B High: $1.24B avg. 7.39% | Avg: $1.33B Low: $1.32B High: $1.34B avg. 8.48% | Avg: $1.49B Low: $1.48B High: $1.50B avg. 11.89% |
FAQ
What is Globus Medical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 64.36% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is 246.45M, average is 380.91M and high is 363.37M.
What is Globus Medical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 24.21% in 2025-2028.
We have gathered data from 12 analysts. Their low revenue estimate is $2.64B, average is $2.65B and high is $2.67B.
What is Globus Medical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 56.30% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is $2.15, average is $2.78 and high is $3.17.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Globus Medical stock. The most successful analyst is Kallum Titchmarsh.